Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × INDUSTRY × NSCLC × Clear all

Phase

Phase 2 13 Phase 3 8 Phase 1/2 8 Phase 1 6 Phase NA 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

OTHER 4 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 54 Breast Neoplasms 54 Prostatic Neoplasms 35 Carcinoma, Non-Small-Cell Lung 34 Neoplasm Metastasis 20 Colorectal Neoplasms 18 Pain 17 Multiple Myeloma 15 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Anemia 14 Keratosis, Actinic 12 Lung Neoplasms 11 Carcinoma, Renal Cell 10 Cancer Pain 10 Lymphoma, Non-Hodgkin 9 Lymphoma, Follicular 9 Leukemia 9 Carcinoma, Hepatocellular 9 Carcinoma 9 Melanoma 8 Leukemia, Lymphocytic, Chronic, B-Cell 7 Uterine Cervical Neoplasms 6 Recurrence 6 Ovarian Neoplasms 6 Neuroendocrine Tumors 6 Lymphoma 6 Stomatitis 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Myeloid, Acute 5 Glioblastoma 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02404675 2017-07-28

INCREASE

Betta Pharmaceuticals Co., Ltd.

Phase 4 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡